Welcome to LookChem.com Sign In|Join Free
  • or
C18H17N5O3S is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1384101-93-2

Post Buying Request

1384101-93-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1384101-93-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1384101-93-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,8,4,1,0 and 1 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1384101-93:
(9*1)+(8*3)+(7*8)+(6*4)+(5*1)+(4*0)+(3*1)+(2*9)+(1*3)=142
142 % 10 = 2
So 1384101-93-2 is a valid CAS Registry Number.

1384101-93-2Relevant academic research and scientific papers

Inhibitors of Dengue virus and West Nile virus proteases based on the aminobenzamide scaffold

Aravapalli, Sridhar,Lai, Huiguo,Teramoto, Tadahisa,Alliston, Kevin R.,Lushington, Gerald H.,Ferguson, Eron L.,Padmanabhan,Groutas, William C.

, p. 4140 - 4148 (2012/09/08)

Dengue and West Nile viruses (WNV) are mosquito-borne members of flaviviruses that cause significant morbidity and mortality. There is no approved vaccine or antiviral drugs for human use to date. In this study, a series of functionalized meta and para aminobenzamide derivatives were synthesized and subsequently screened in vitro against Dengue virus and West Nile virus proteases. Four active compounds were identified which showed comparable activity toward the two proteases and shared in common a meta or para(phenoxy)phenyl group. The inhibition constants (Ki) for the most potent compound 7n against Dengue and West Nile virus proteases were 8.77 and 5.55 μM, respectively. The kinetics data support a competitive mode of inhibition of both proteases by compound 7n. This conclusion is further supported by molecular modeling. This study reveals a new chemical scaffold which is amenable to further optimization to yield potent inhibitors of the viral proteases via the combined utilization of iterative medicinal chemistry/structure-activity relationship studies and in vitro screening.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1384101-93-2